alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
| Name                                                                                  |   | Jurisdiction |
|---------------------------------------------------------------------------------------|--------|--------------|
| GeoPark Argentina Limited− Bermuda                                              |   | Bermuda      |
| GeoPark Argentina Limited –Argentinean Branch                                   |   | Argentina    |
| GeoPark Latin America Limited −Bermuda                                          |   | Bermuda      |
| GeoPark Latin America −Agencia en Chile                                         |   | Chile        |
| GeoPark S.A.                                                                          |   | Chile        |
| GeoPark Brazil Exploração y Produção de Petróleo e Gas Ltda. |   | Brazil       |
| GeoPark Chile S.A.                                                                    |   | Chile        |
| GeoPark Fell S.p.A.                                                                   |   | Chile        |
| GeoPark Magallanes Limitada                                                           |   | Chile        |
| GeoPark TdF S.A.                                                                      |   | Chile        |
| GeoPark Colombia S.A.                                                                 |   | Chile        |
| GeoPark Colombia SAS                                                                  |   | Colombia     |
| GeoPark Brazil S.p.A.                                                                 |   | Chile        |
| GeoPark Latin America Cooperatie U.A.                                                 |   | Netherlands  |
| GeoPark Colombia Cooperatie U.A.                                                      |   | Netherlands  |
| GeoPark Brazil Cooperatie U.A.                                                        |   | Netherlands  |
| Servicios Southern Cross Limitada                                                     |   | Chile        |
| Rio das Contas Productora de Petroleo Ltda                                            |   | Brazil       |

----
**Exhibit
        32.2**
  **CERTIFICATION
        PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**
 **SECTION
        906 OF THE SARBANES-OXLEY ACT OF 2002**
  Pursuant
        to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of
        2002, the undersigned officer of Global Clean Energy Holdings, Inc. (the
        “Company”) hereby certifies that, to the best of his knowledge:
  (i)  The
        Quarterly Report on Form 10-Q of the Company for the quarter ended March
        31,
        2008 (the “Report”) fully complies with the requirements of Section 13(a) or
        Section 15(d), as applicable, of the Securities Exchange Act of 1934, as
        amended; and
  (ii)  The
        information contained in the Report fairly presents, in all material respects,
        the financial condition and results of operations of the Company.
 Date:
                        May 13, 2008
                    By:
                    /s/
                        BRUCE NELSONBruce
                        NelsonChief
                        Financial Officer
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                          776040
<SECURITIES>                                   5172784
<RECEIVABLES>                                  3297995
<ALLOWANCES>                                    117000
<INVENTORY>                                     576887
<CURRENT-ASSETS>                               9906814
<PP&E>                                         7611129
<DEPRECIATION>                                 4840947
<TOTAL-ASSETS>                                18016750
<CURRENT-LIABILITIES>                          4721706
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        771286
<OTHER-SE>                                     9370514
<TOTAL-LIABILITY-AND-EQUITY>                  18016750
<SALES>                                        6180796
<TOTAL-REVENUES>                               6180796
<CGS>                                           829046
<TOTAL-COSTS>                                  5342271
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                117000
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 860556
<INCOME-TAX>                                     30000
<INCOME-CONTINUING>                             830556
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    830556
<EPS-BASIC>                                        .11
<EPS-DILUTED>                                      .10


</TABLE>
| (1) | the      Quarterly Report on Form 10-Q of the Registrant for the period ended      September 30, 2009, as filed with the Securities and Exchange      Commission (the “Report”), fully complies with the requirements of      Section 13(a) of the Securities Exchange Act of 1934;    and |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | the      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of the      Registrant. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                          |                                                       |
|-------------------------------|------------------------------------------------------------|
| Dated:      November 13, 2009 | /s/      KENDRA BERGER       |
|                          | Kendra      Berger                                         |
|                          | Chief      Financial Officer                               |
|                          | NTN      Buzztime, Inc.                                    |
BAYFRONT HEALTH DADE CITY and Gallagher Bassett Services, Inc., Appellant, v. Herman WILLIAMS III, Appellee.

No. 1D17-1736

District Court of Appeal of Florida, First District.

January 12, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Alcohol Abuse and Alcoholism, Special Emphasis Panel. AA3 Deferred Applications.                    

*Date:*                         April 22, 2009.                    

*Time:*                         2 p.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         NIH/NIAAA, 5635 Fishers Lane, Bethesda, MD 20892 (Telephone Conference Call).                    

*Contact Person:*                         Katrina L Foster, PhD, Scientific Review Officer, National Inst on Alcohol Abuse & Alcoholism, National Institutes of Health, 5635 Fishers Lane, Rm. 2019, Rockville, MD 20852, 301-443-4032.                         *katrina@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants, National Institutes of Health, HHS)

Dated: March 25, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

 [FR Doc. E9-7319 Filed 4-2-09; 8:45 am]

BILLING CODE 4140-01-M
[Federal Register Volume 74, Number 64 (Monday, April 6, 2009)]
[Notices]
[Pages 15574-15575]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-7675]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 6567]


Determination and Certification Under Section 490(b)(1)(A) of the 
Foreign Assistance Act Relating to the Largest Exporting and Importing 
Countries of Certain Precursor Chemicals

    Pursuant to Section 490(b)(1)(A) of the Foreign Assistance Act of 
1961, as amended, I hereby determine and certify that the top five 
exporting and importing countries and territories of pseudoephedrine 
and ephedrine (India, Germany, Singapore, Belgium, United Kingdom, 
China, Taiwan, Argentina, South Korea, Switzerland, Indonesia, and 
Thailand) have cooperated fully with the United States, or have taken 
adequate steps on their own, to achieve full compliance with the goals 
and objectives established by the United Nations Convention Against 
Illicit Traffic in Narcotic Drugs and Psychotropic Substances.
    This determination and certification shall be published in the 
Federal Register, and copies shall be provided to the Congress together 
with the accompanying Memorandum of Justification.


[[Page 15575]]


    Dated: March 3, 2009.
James B. Steinberg,
Deputy Secretary of State, Department of State.
 [FR Doc. E9-7675 Filed 4-3-09; 8:45 am]
BILLING CODE 4710-17-P
Document

									
	
		                                                    Exhibit 10.75                                                         Daniel S. Glaser                                 President and Chief Executive Officer
			Marsh McLennan
1166 Avenue of the Americas
New York, NY 10036
T +1 212 345 5000
www.mmc.com





December 1, 2021


John Q. Doyle
Hand delivery


Subject: Terms of Employment


Dear John,
This amendment to the Letter Agreement, dated September 14, 2017, between you and Marsh & McLennan Companies, Inc. as subsequently amended on February 19, 2020 (together, the “Letter Agreement”), revises the terms and conditions of your employment previously by Marsh LLC as its President and Chief Executive Officer.  The Letter Agreement will continue to govern your employment except as specified below:  
1.    You will now be employed by Marsh & McLennan Companies, Inc.


2.    Your title is Group President and Chief Operating Officer and Vice Chair, Marsh McLennan.


3.    Exhibit A to the Letter Agreement shall be deleted and replaced in its entirety with the attached Exhibit A.
The terms of this amendment are effective as of January 1, 2022.  Please acknowledge your agreement with the terms of the Letter Agreement, as further amended by this second amendment, by signing and dating this and the enclosed copy and returning one to me. 


Sincerely,


/s/ Daniel S. Glaser
Daniel S. Glaser
President and Chief Executive Officer
Marsh McLennan
			
	
	








Page 2
December 1, 2021
John Q. Doyle





Accepted and Agreed:






/s/ John Q. Doyle
(Signature)
    




December 2, 2021
(Date)




















































			
	
	








Page 3
December 1, 2021
John Q. Doyle



Exhibit A


						
	Board or Committee Memberships	    The Board of the Greenberg School of Risk Management at St John’s University
    The Board of New York Police and Fire Widows and Children’s Benefit Fund 
    Inner City Scholarship Fund

	Annual Base Salary	$1,200,000 effective as of January 1, 2022.
	Annual Target Bonus Opportunity	Bonus awards are discretionary.  Target bonus of $2,800,000 commencing with the 2022 performance year (awarded in February 2023).  Actual bonus may range from 0% - 200% of target, based on achievement of individual performance objectives, Marsh McLennan’s performance as Marsh McLennan may establish from time to time.
	Annual Target Long-Term Incentive Opportunity	Long-term incentive awards are discretionary.  Target award value of $4,000,000, commencing with the award made in 2022.
Mary S. WEBB, Appellant/Petitioner(s), v. Leada A. COLLINS, Appellee/Respondent(s).

CASE NO.: 2D14-2273

District Court of Appeal of Florida, Second District.

June 12, 2014

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
Jeffrey GRONDIN, a/k/a Jeffrey G. Grondin, Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-2983

District Court of Appeal of Florida, Second District.

Opinion filed November 22, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Antonial SMITH, Appellant, v. The STATE of Florida, Appellee.

No. 3D17-1795

District Court of Appeal of Florida, Third District.

Opinion filed February 7, 2018.

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
APPENDIX E 

PARTICLE ANALYSIS REPORT
E-1
E-2
E-3
E-4
E-5
E-6
E-7
E-8
E-9
E-10
[Federal Register Volume 83, Number 13 (Friday, January 19, 2018)]
[Notices]
[Page 2807]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00867]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Microbiology, 
Infectious Diseases and AIDS Initial Review Group Microbiology and 
Infectious Diseases B Subcommittee.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in sections 552b(c)(6), Title 
5 U.S.C., as amended for review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Institute of Allergy and Infectious Diseases, including consideration 
of personnel qualifications and performance, and the competence of 
individual investors, the disclosure of which would constitue a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Microbiology, Infectious Diseases and AIDS 
Initial Review Group, Microbiology and Infectious Diseases B 
Subcommittee MID-B, February 2018.
    Date: February 12-13, 2018.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bahia Resort Hotel, 3999 West Mission Bay Drive, San 
Diego, CA 92109.
    Contact Person: Ellen S. Buczko, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 6700B Rockledge 
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-451-2676, 
<a href="/cdn-cgi/l/email-protection#f7929582948d9c98c6b7999e969e93d9999e9fd9909881"><span class="__cf_email__" data-cfemail="21444354425b4a4e10614f484048450f4f48490f464e57">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 10, 2018.
 Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-00867 Filed 1-18-18; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from
Sterling Drilling Fund 1984-1 second quarter 1998 10Q and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                           1,882
<SECURITIES>                                         0
<RECEIVABLES>                                   25,602
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                27,484
<PP&E>                                       7,982,144
<DEPRECIATION>                              (6,983,185)
<TOTAL-ASSETS>                               1,026,443
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   1,026,443<F1>
<TOTAL-LIABILITY-AND-EQUITY>                 1,026,443
<SALES>                                        146,731<F2>
<TOTAL-REVENUES>                               146,731
<CGS>                                          135,311
<TOTAL-COSTS>                                  135,311
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    11,420
<EPS-PRIMARY>                                     0.58<F3>
<EPS-DILUTED>                                        0
<FN>
<F1>Other -se includes total partner's equity.
<F2>Sales includes $688 of interest income.
<F3>The limited partner's share of net income
was divided by the total number of limited
partnership units of 9,236.
</FN>
        

</TABLE>
**Exhibit 32.01**

 

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the KMG America Corporation Amendment No. 1 to the Annual Report on Form 10-K for the period ended December 31, 2005, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 (1)        The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 (2)        The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of KMG America Corporation.

 
| /s/ Kenneth U. Kuk | Date: March 15, 2006 |
|--------------------|----------------------|

Kenneth U. Kuk

Chairman, President & Chief Executive Officer

(Principal Executive Officer)
Cynthia G. HOGG, Appellant, v. TARGET CORPORATION and Premier Striping, Inc., Appellees.

Case No. 2D16-5253

District Court of Appeal of Florida, Second District.

Opinion filed November 22, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
IV 

118TH CONGRESS 

1ST SESSION H. RES. 849 

Reaffirming the State of Israel’s right to exist, condemning antisemitism 

in all forms, and rejecting false equivalencies between democracies and 

terrorist organizations. 

IN THE HOUSE OF REPRESENTATIVES 

NOVEMBER 7, 2023 

Mr. BUCK submitted the following resolution; which was referred to the 

Committee on Foreign Affairs 

RESOLUTION 

Reaffirming the State of Israel’s right to exist, condemning 

antisemitism in all forms, and rejecting false equivalencies between democracies and terrorist organizations. 

Whereas the United States has been a friend to the State of 

Israel since its inception in 1948; 

Whereas Israel has been a friend and ally to the United 

States in the Middle East, especially in the Global War 

on Terror; 

Whereas the Jewish State was formed from necessity after 

millennia of pogroms, persecutions, and a Holocaust; 

Whereas Members of this body have trafficked antisemitic 

tropes, created and propagated false narratives, and expressed false equivalencies between the Israeli Government and the terrorists attacking them; 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HRES 849 IH 

Whereas Hamas attacked the sovereign country of Israel on 

October 7, 2023, slaughtering innocent civilians, including women and children; 

Whereas Hamas captured hundreds of civilians in the October 7 attack, including United States civilians, and seeks 

to use those hostages as human shields in their war with 

the Israeli military; and 

Whereas antisemitic hate crimes have increased since October 

7: Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) reaffirms the right of Israel to exist and de3 fend her citizens against terrorist organizations and 

4 their state backers; 

5 (2) condemns the violence perpetrated by 

6 Hamas on October 7 and rejects the notion that 

7 such violence can be justified by political concerns; 

8 (3) rejects any moral equivalence between the 

9 Israeli Government and the Hamas regime that 

10 starves its citizens, abuses its population, and uses 

11 them as human shields; 

12 (4) demands the safe return of all hostages 

13 taken by Hamas in the October 7 atrocity; 

14 (5) rejects the false narrative that Israeli forces 

15 targeted Al-Ahli Arab Hospital on October 17, 2023; 

16 (6) rejects the false narrative that United 

17 States security assistance to Israel in any way con18 tributed to the October 7 atrocities; 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HRES 849 IH 

1 (7) condemns the phrase ‘‘from the river to the 

2 sea, Palestine will be free’’ as an expression of sup3 port for genocide, murder, and ethnic cleansing; and 

4 (8) rejects the idea that phrasing centering on 

5 the destruction and violent expulsion of Jews from 

6 their ancestral homeland is anything other than eth7 nic cleansing. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB